Effects of low-dose dopamine on ventilation in patients with chronic obstructive pulmonary disease

European Journal of Clinical Investigation

Volumn 34, Issue 7, 2004, Pages 508-512

  Ciarka, A ^a   Rimacchi, R ^a   Vincent, J L ^a   Velez Roa, S ^a   Dumonceaux, M ^a   Leeman, M ^a   Van De Borne, P ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Chemoreflex; COPD; Dopamine

Indexed keywords

DOPAMINE; PLACEBO;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BREATHING; BREATHING RATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HEART RATE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; LUNG MINUTE VOLUME; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AGED; CROSS-OVER STUDIES; DOPAMINE; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY;

EID: 3943086199     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01375.x     Document Type: Article

References (41)

1. Hoffman B, Lefkowitz R. Catecholamines and sympathomimetic drugs. In: Gilman A, Rall T, Nies A, Taylor P, editors. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York: Pergamon Press; 1990. pp. 187-220.
2. Philip-Joet F, Saadjian A, Vestri R, Tran GA, Arnaud A. Hemodynamic effects of a single dose of dopamine and 1-dopa in pulmonary hypertension secondary to chronic obstructive lung disease. Respiration 1988;53:146-52.
3. Chan TY. Low-dose dopamine in severe right heart failure and chronic obstructive pulmonary disease. Ann Pharmacother 1995;29:493-6.
4. Szerlip HM. Renal-dose dopamine: fact and fiction. Ann Intern Med 1991;115:153-4.
5. Cheng EY, Nimphius N. Effectiveness of bumetanide with low-dosage dopamine for diuresis. Ann Pharmacother 1993;27:238-9.
6. Aubier M, Murciano D, Menu Y, Boczkowski J, Mal H, Pariente R. Dopamine effects on diaphragmatic strength during acute respiratory failure in chronic obstructive pulmonary disease. Ann Intern Med 1989;110:17-23.
7. Chiocchio SR, Biscardi AM, Tramezzani JH. Catecholamines in the carotid body of the cat. Nature 1966;212:834-5.
8. Dearnaley DP, Fillenz M, Woods RI. The identification of dopamine in the rabbit's carotid body. Proc R Soc Lond B Biol Sci 1968;170:195-203.
9. Hellstrom S, Hanbauer I, Costa E. Selective decrease of dopamine content in rat carotid body during exposure to hypoxic conditions. Brain Res 1976;118:352-5.
10. Niemi M, Ojala K. Cytochemical demonstration of catecholamines in the human carotid body. Nature 1964;203:539-40.
11. Steele RH, Hinterberger H. Catecholamines and 5-hydroxytryptamine in the carotid body in vascular, respiratory, and other diseases. J Lab Clin Med 1972;80:63-70.
12. Zapata P, Hess A, Bliss EL, Eyzaguirre C. Chemical, electron microscopic and physiological observations on the role of catecholamines in the carotid body. Brain Res 1969;14:473-96.
13. Ide T, Shirahata M, Chou CL, Fitzgerald RS. Effects of a continuous infusion of dopamine on the ventilatory and carotid body responses to hypoxia in cats. Clin Exp Pharmacol Physiol 1995;22:658-64.
14. Black AM, Comroe JH Jr, Jacobs L. Species difference in carotid body response of cat and dog to dopamine and serotonin. Am J Physiol 1972;223:1097-102.
15. Bisgard GE, Forster HV, Klein JP, Manohar M, Bullard VA. Depression of ventilation by dopamine in goats - effects of carotid body excision. Respir Physiol 1980;40:379-92.
16. Lagneaux D, Lecomte J. [Dopamine and the chemoregulation of ventilation in the rat.] Arch Int Physiol Biochim 1984;92:263-5.
17. Llados F, Zapata P. Effects of dopamine analogues and antagonists on carotid body chemosensors in situ. J Physiol 1978;274:487-99.
18. Olson LG, Saunders NA. Ventilatory stimulation by dopamine-receptor antagonists in the mouse. Br J Pharmacol 1985;85:133-41.
19. Zapata P, Zuazo A. Reversal of respiratory responses to dopamine after dopamine antagonists. Respir Physiol 1982;47:239-55.
20. Ward DS, Bellville JW. Reduction of hypoxic ventilatory drive by dopamine. Anesth Analg 1982;61:333-7.
21. Welsh MJ, Heistad DD, Abboud FM. Depression of ventilation by dopamine in man. Evidence for an effect on the chemoreceptor reflex. J Clin Invest 1978;61:708-13.
22. Bainbridge CW, Heistad DD. Effect of haloperidol on ventilatory responses to dopamine in man. J Pharmacol Exp Ther 1980;213:13-7.
23. Olson LG, Hensley MJ, Saunders NA. Ventilatory responsiveness to hypercapnic hypoxia during dopamine infusion in humans. Am Rev Respir Dis 1982;126:783-7.
24. Van de Borne P, Oren R, Somers VK. Dopamine depresses minute ventilation in patients with heart failure. Circulation 1998;98:126-31.
25. Gonzalez C, Kwok Y, Gibb J, Fidone S. Effects of hypoxia on tyrosine hydroxylase activity in rat carotid body. J Neurochem 1979;33:713-9.
26. Fidone SJ, Gonzalez C, Yoshizaki K. Putative neurotransmitters in the carotid body: the case for dopamine. Fed Proc 1980;39:2636-40.
27. Hanbauer I, Hellstrom S. The regulation of dopamine and noradrenaline in the rat carotid body and its modification by denervation and by hypoxia. J Physiol 1978;282:21-34.
28. Docherty RJ, McQueen DS. Inhibitory effects of acetylcholine and dopamine on rabbit carotid chemoreceptors [proceedings]. J Physiol 1978;277:64P-6P.
29. Lahiri S, Nishino T. Inhibitory and excitatory effects of dopamine on carotid chemoreceptors. Neurosci Lett 1980;20:313-8.
30. Sampson SR, Aminoff MJ, Jaffe RA, Vidruk EH. Analysis of inhibitory effect of dopamine on carotid body chemoreceptors in cats. Am J Physiol 1976;230:1494-8.
31. Debaveye YA, Van den Berghe GH. Is there still a place for dopamine in the modern intensive care unit? Anesth Analg 2004;98:461-8.
32. Van de Borne P, Somers VK. Dopamine and congestive heart failure: pharmacology, clinical use, and precautions. Congest Heart Fail 1999;5:216-21.
33. Varriale P, Mossavi A. The benefit of low-dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: does it protect renal function? Clin Cardiol 1997;20:627-30.
34. Varriale P. Role of dopamine in congestive heart failure: a contemporary appraisal. Congest Heart Fail 1999;5:120-4.
35. Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Banasiak W et al. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 2001;104:544-9.
36. Narkiewicz K, Pesek CA, van de Borne PJ, Kato M, Somers VK. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 1999;100:262-7.
37. Erbland ML, Ebert RV, Snow SL. Interaction of hypoxia and hypercapnia on respiratory drive in patients with COPD. Chest 1990;97:1289-94.
38. Fahey PJ, Hyde RW. 'Won't breathe' vs 'can't breathe'. Detection of depressed ventilatory drive in patients with obstructive pulmonary disease. Chest 1983;84:19-25.
39. Scano G, Spinelli A, Duranti R, Gorini M, Gigliotti F, Goti P et al. Carbon dioxide responsiveness in COPD patients with and without chronic hypercapnia. Eur Respir J 1995;8:78-85.
40. Whitelaw WA, Derenne JP, Milic-Emili J. Occlusion pressure as a measure of respiratory center output in conscious man. Respir Physiol 1975;23:181-99.
41. Whitelaw WA, Derenne JP. Airway occlusion pressure. J Appl Physiol 1993;74:1475-83.